Palisade Bio, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US6963892046

USD

1.80

0.00 (0.00%)

Dec 05

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sonoma Pharmaceuticals, Inc.

Jaguar Health, Inc.

Tempest Therapeutics, Inc.

Synaptogenix, Inc.

Cyclacel Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc.

Artelo Biosciences, Inc.

Palisade Bio, Inc.

ZyVersa Therapeutics, Inc.

Petros Pharmaceuticals, Inc.

Universe Pharmaceuticals, Inc.

Why is Palisade Bio, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Palisade Bio, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Palisade Bio, Inc.

2.86%

-0.37

142.52%

S&P 500

12.66%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.20%

EBIT Growth (5y)

-12.30%

EBIT to Interest (avg)

-12.12

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.35

Sales to Capital Employed (avg)

0.02

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.77%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.63

EV to EBIT

0.28

EV to EBITDA

0.28

EV to Capital Employed

2.08

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

733.08%

ROE (Latest)

-246.48%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -9.66 MM

NET PROFIT(HY)

Higher at USD -5 MM

DEBT-EQUITY RATIO (HY)

Lowest at -193.85 %

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-2What is not working for the Company

ROCE(HY)

Lowest at -188.48%

Here's what is working for Palisade Bio, Inc.

Net Profit

Higher at USD -5 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Debt-Equity Ratio

Lowest at -193.85 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Operating Cash Flow

Highest at USD -9.66 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales